HN2009000012A - PHARMACEUTICAL COMPOSITION CONTAINING A TETRAHYDROPHOLIC ACID - Google Patents
PHARMACEUTICAL COMPOSITION CONTAINING A TETRAHYDROPHOLIC ACIDInfo
- Publication number
- HN2009000012A HN2009000012A HN2009000012A HN2009000012A HN2009000012A HN 2009000012 A HN2009000012 A HN 2009000012A HN 2009000012 A HN2009000012 A HN 2009000012A HN 2009000012 A HN2009000012 A HN 2009000012A HN 2009000012 A HN2009000012 A HN 2009000012A
- Authority
- HN
- Honduras
- Prior art keywords
- tetrahydropholic
- pharmaceutical composition
- composition containing
- strogen
- progestagen
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- WAHQVRCNDCHDIB-QZYSPNBYSA-N [(3s,8r,9s,10r,13s,14s,17r)-17-acetyl-17-acetyloxy-6,10,13-trimethyl-1,2,3,8,9,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-yl] 3-cyclopentylpropanoate Chemical compound O([C@@H]1C=C2C(C)=C[C@H]3[C@@H]4CC[C@]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)(OC(=O)C)C(C)=O)C(=O)CCC1CCCC1 WAHQVRCNDCHDIB-QZYSPNBYSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000000583 progesterone congener Substances 0.000 abstract 2
- MXAZMWGALDAMFV-JBBJNLNBSA-N (8R,9S,13S,14S)-15-ethyl-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol Chemical compound OC1=CC=C2[C@H]3CC[C@]4(C)C(O)CC(CC)[C@H]4[C@@H]3CCC2=C1 MXAZMWGALDAMFV-JBBJNLNBSA-N 0.000 abstract 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- METQSPRSQINEEU-UHFFFAOYSA-N dihydrospirorenone Natural products CC12CCC(C3(CCC(=O)C=C3C3CC33)C)C3C1C1CC1C21CCC(=O)O1 METQSPRSQINEEU-UHFFFAOYSA-N 0.000 abstract 1
- METQSPRSQINEEU-HXCATZOESA-N drospirenone Chemical compound C([C@]12[C@H]3C[C@H]3[C@H]3[C@H]4[C@@H]([C@]5(CCC(=O)C=C5[C@@H]5C[C@@H]54)C)CC[C@@]31C)CC(=O)O2 METQSPRSQINEEU-HXCATZOESA-N 0.000 abstract 1
- 229960004845 drospirenone Drugs 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
ESTA INVENCION SE REFIERE A COMPOSICIONES FARMACEUTICAS SOLIDAS,EN PARTICULAR ANTICOPCEPTIVOS ORALES, QUE COMPRENDEN UN PROGESTAGENO, TAL COMO DROSPIRENONA; UN ESTROGENO, TAL COMO ETILNILESTRADIOL; UN ACIDO TETRAHIDROFOLICO O UNA DE SUS SALES ADECUADAS PARA USO FARMACEUTICO, TAL COMO 5-METIL-(6S)-TETRAHIDROFOLATO DE CALCIO; Y POR O MENOS UN EXCIPIENTE O VEHICULO ADECUADO PARA USO FARMACEUTICO. LAS COMPOSICIONES DE LA INVENCION PROPORCIONAN BUENA ESTABILIDAD DEL ACIDO TETRAHIDROFOLICO DURANTE EL ALMACENAMIENTO ASEGURANDO NO OBSTANTE UNA LIBERACION RAPIDA Y CONFIABLE DEL ESTROGENO Y DEL PROGESTAGENO PRESENTES EN LA COMPOSICION.THIS INVENTION REFERS TO SOLID PHARMACEUTICAL COMPOSITIONS, IN PARTICULAR ORAL ANTICOPCEPTIVES, THAT UNDERSTAND A PROGESTAGEN, AS DROSPIRENONE; A STROGEN, SUCH AS ETHYLESTRADIOL; A TETRAHYDROPHOLIC ACID OR ONE OF ITS SUITS SUITABLE FOR PHARMACEUTICAL USE, SUCH AS 5-METHYL- (6S) -THE CALCIUM TETRAHYDROPHOLATE; AND FOR OR LESS A SUITABLE EXCIPIENT OR VEHICLE FOR PHARMACEUTICAL USE. THE COMPOSITIONS OF THE INVENTION PROVIDE GOOD STABILITY OF THE TETRAHYDROPHOLIC ACID DURING STORAGE, INSURING NON-OBTAINING A QUICK AND RELIABLE RELEASE OF THE STROGEN AND OF THE PROGESTAGEN PRESENT IN THE COMPOSITION.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP60140027 | 2006-07-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HN2009000012A true HN2009000012A (en) | 2011-04-25 |
Family
ID=46801762
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HN2009000012A HN2009000012A (en) | 2006-07-06 | 2009-01-06 | PHARMACEUTICAL COMPOSITION CONTAINING A TETRAHYDROPHOLIC ACID |
Country Status (1)
| Country | Link |
|---|---|
| HN (1) | HN2009000012A (en) |
-
2009
- 2009-01-06 HN HN2009000012A patent/HN2009000012A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GT200900001A (en) | PHARMACEUTICAL COMPOSITION CONTAINING A HYDROPHOLIC TETRA ACID | |
| DOP2011000402A (en) | PHARMACEUTICAL COMPOSITION FOR EMERGENCY ANTI-CONCEPTION | |
| CL2013001338A1 (en) | Compounds derived from substituted benzothiene-pyridines, hiv replication inhibitors; pharmaceutical composition that includes them; pharmaceutical combination; pharmaceutical kit; and its use for the treatment of hiv. | |
| HN2012001162A (en) | TRIAZOLOPIRIDINS | |
| CR9531A (en) | PHARMACEUTICAL COMPOSITION CONTAINING GESTAGENS AND / OR STROGENS AND 5-METHYL- (6S) -TETRAHYDROPHOLATE | |
| CL2008003284A1 (en) | Compounds derived from 4-benzylamino-1-carboxyacyl-pyridine, cetp inhibitors; pharmaceutical composition comprising them; pharmaceutical combination; and use in the treatment of metabolic, atherosclerosis and cardiovascular diseases, among others. | |
| CL2008000946A1 (en) | COMPOUNDS DERIVED FROM PIRROLOPIRIMIDINA, INHIBITORS OF CIANASA JAK3; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF REPLACEMENT OF TRANSPLANTS, AUTOIMMUN DISEASES | |
| HN2005000795A (en) | PYRIMIDINS AS ANTAGONISTS OF PROSTAGLANDINA D2 RECEPTOR | |
| ECSP099250A (en) | USE OF 2-6- (3-amino-piperidin-1-Il) -3-methyl-2,4-dioxo-3,4-dihIdro-2H-pIrimidin-1-IlmetIL-4-fluoro-benzonitrile | |
| ECSP12012353A (en) | COMPOUNDS, THIOACETATE COMPOSITIONS AND METHODS OF USE | |
| CL2011001658A1 (en) | Sulfonamide derivatives, sodium channel modulators; pharmaceutical composition comprising them; and its use in the treatment of pain. | |
| BR112015000229A2 (en) | stable aqueous formulations of etanercept | |
| DOP2011000382A (en) | HETEROCICLIC SULFONAMIDS, USES AND PHARMACEUTICAL COMPOSITIONS OF THE SAME | |
| UY32315A (en) | PIPERIDINE COMPOUNDS AND USES OF THE SAME-596 | |
| AR116001A2 (en) | PHARMACEUTICAL COMPOSITION 271 | |
| EA201101116A1 (en) | PHARMACEUTICAL COMPOSITIONS, INCLUDING 2-OXO-1-PYRROLIDINE DERIVATIVES | |
| GT200600346A (en) | NEW CRYSTAL FORMULA V OF AGOMELATINE, A PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT | |
| EA201101118A1 (en) | PHARMACEUTICAL COMPOSITIONS, INCLUDING 2-OXO-1-PYRROLIDINE DERIVATIVES | |
| UY31128A1 (en) | FORMULATION OF NEVIRAPINE OF PROLONGED RELEASE | |
| AR087371A1 (en) | FORMULATIONS OF (TRIMETOXIFENILAMINO) PYRIMIDINYL, METHODS | |
| ECSP19026563A (en) | SUBSTITUTE DERIVATIVES OF 6- (1H-PYRAZOLE-1-IL) PYRIMIDIN-4-AMINE AND USES THEREOF | |
| GT200500358A (en) | ORGANIC COMPOUNDS | |
| ECSP088464A (en) | COMPOSITE FOR THE INHIBITION OF APOPTOSIS | |
| HN2009000012A (en) | PHARMACEUTICAL COMPOSITION CONTAINING A TETRAHYDROPHOLIC ACID | |
| PL2065035T3 (en) | Pharmaceutical formulations containing irbesartan |